MedPath

Utility of Multisensory Body-Representation in Spinal Cord Injury (SCI) With Pain

Not Applicable
Recruiting
Conditions
Neuropathic Pain
Spinal Cord Injuries
Interventions
Other: tDCS and bodily illusions
Registration Number
NCT06010251
Lead Sponsor
University of Miami
Brief Summary

The purpose of this study is to investigate the effectiveness of bodily illusions combined with transcranial direct current stimulation (tDCS) on neuropathic pain symptoms and sensory functions in participants with spinal cord injury (SCI) and neuropathic pain.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
SCI with paintDCS and bodily illusionsParticipants will undergo 2-4 weeks of combined intervention including transcranial direct current stimulation (tDCS) and bodily illusions (10 sessions total).
Primary Outcome Measures
NameTimeMethod
Changes associated with sensory function/dysfunction assessed by quantitative sensory testingBaseline, up to 4 weeks

The sensory test assesses thermal thresholds and includes:

cool detection threshold (CDT), warm detection threshold (WDT), cold pain threshold (CPT), hot pain threshold (HPT), all performed using the method of limits: 0 to 50 Celsius (ºC) all values will be reported in Celsius.

Change in neuropathic pain interference assessed by pain interference questionnaire.Baseline, up to 4 weeks

The questionnaire consists in a numerical rating of pain interference ranging from 0= No Interference to 10=Extreme interference with activities, mood and sleep

Change in neuropathic pain severity assessed by Neuropathic Pain Symptom Inventory (NPSI)Baseline, up to 4 weeks

The NPSI is a self-reported, validated questionnaire that includes 10 items (on different pain sensations, e.g., burning, squeezing, electric-shock, etc.) used to evaluate the properties of neuropathic pain. Each item is scored on an 11-point NRS (0 meaning no symptom and 10 meaning worst symptom), with higher scores indicating more severe neuropathic pain symptoms.

Secondary Outcome Measures
NameTimeMethod
Changes of psychosocial assessed by Multidimensional Pain Inventory (pain severity subscale)Baseline, up to 4 weeks

Multidimensional Pain Inventory assesses the psychosocial impact of pain. This scale consists of three questions: 1) pain at the present moment; 2) pain during the past week and 3) suffering because of pain.

The range of the responses are from 0 (no pain or suffering) to 6 (extreme pain or suffering) and the scores of these three questions will be summed to obtain a composite pain severity score.

Change in Global impression of changes by PGIC questionnaireBaseline, up to 4 weeks

Patients' Global Impression of Changes (PGIC) assesses patients' perceptions of changes following treatment. It is a 7-point verbal scale, with the options ranging from "very much improved" (3), "much improved" (2), "minimally improved" (1), "no change" (0), "minimally worsened" (-1) "much worsened" (-2), and "very much worsened" (-3).

Change in manageable pain assessed by days of manageable pain questionnaire.Baseline, up to 4 weeks

This item specifies the total number of days with pain during the last 7 days, including today, and the response categories ranges from 0=none to 7=seven days.

Trial Locations

Locations (1)

University of Miami

🇺🇸

Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath